Skip to main content
Log in

Preventive effect of ginsenoid on chronic bacterial prostatitis

  • Original Article
  • Published:
Journal of Infection and Chemotherapy

Abstract

Empirical antibiotic therapy is the preferred primary treatment modality for chronic bacterial prostatitis (CBP). However, this method of treatment has a low success rate and long-term therapy may result in complications and the appearance of resistant strains. Therefore a new alternative method for the prevention of CBP is necessary. There are several reports that ginsenoid has a preventive effect on urinary tract infection (UTI). To evaluate the preventive effect of ginsenoid on CBP compared to conventional antibiotics, we carried out an experiment in a rat model of the disease. Four groups of adult male Wistar rats were treated with the following medications: (1) control (no medication), (2) ciprofloxacin, (3) ginsenoid, and (4) ciprofloxacin/ginsenoid. All medications were given for 4 weeks, and then we created a CBP model in the animals by injecting an Escherichia coli Z17 (O2:K1;H) suspension into the prostatic urethra. After 4 weeks, results of microbiological cultures of prostate and urine samples, as well as histological findings of the prostate in each group were analyzed. The microbiological cultures of the prostate samples demonstrated reduced bacterial growth in all experimental groups compared with the control group. Histopathological examination showed a significantly decreased rate of infiltration of inflammatory cells into prostatic tissue and decreased interstitial fibrosis in the ginsenoid group compared with the control group. Inhibition of prostate infection was greater in the group receiving both ginsenoid and antibiotic than in the single-medication groups. Although the findings of this study suggest a preventive effect of ginsenoid, preventive methods for CBP are still controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pfau A. Prostatitis. A continuing enigma. Urol Clin North Am. 1986;13:695–715.

    PubMed  CAS  Google Scholar 

  2. Nickel JC, Olson ME, Costerton JW. Rat model of experimental bacterial prostatitis. Infection. 1991;19(Suppl 3):S126–30.

    Article  PubMed  Google Scholar 

  3. Stamey TA, Meares EM Jr, Winningham DG. Chronic bacterial prostatitis and diffusion of drugs into prostatic fluid. J Urol. 1970;103:187–94.

    PubMed  CAS  Google Scholar 

  4. Nickel JC. Antibiotics for bacterial prostatitis. J Urol. 2000;163:1407.

    Article  PubMed  CAS  Google Scholar 

  5. Song ZJ, Johansen HK, Faber V, Hoiby N. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS. 1997;105:438–44.

    Article  PubMed  CAS  Google Scholar 

  6. Ahn JY, Song JY, Yun YS, Jeong G, Choi IS. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol. 2006;46:187–97.

    Article  PubMed  CAS  Google Scholar 

  7. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol. 2004;133:113–20.

    Article  PubMed  CAS  Google Scholar 

  8. Matsuda H, Samukawa K, Kubo M. Anti-inflammatory activity of ginsenoside ro 1. Planta Med. 1990;56:19–23.

    Article  CAS  Google Scholar 

  9. Yu SC, Li XY. Effect of ginsenoside on IL-1 beta and IL-6 mRNA expression in hippocampal neurons in chronic inflammation model of aged rats. Acta Pharmacol Sin. 2000;21:915–8.

    PubMed  CAS  Google Scholar 

  10. Seo SI, Lee S, Kim JC, Choi Y, Sw SW, Hwang TK, Cho Y. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol. 2003;10:485–91.

    Article  PubMed  CAS  Google Scholar 

  11. Han CH, Yang CH, Sohn DW, Kim SW, Kang SH, Cho YH. Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model. Int J Antimicrob Agents. 2008;31(S1):S102–7.

    Article  PubMed  CAS  Google Scholar 

  12. Lee YS, Han CH, Kang SH, Lee S, Kim SW, Shin OR, Sim Y, Cho Y. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Int J Urol. 2005;12:383–9.

    Article  PubMed  Google Scholar 

  13. Sohn DW, Han CH, Jung YS, Kim SI, Kim SW, Cho Y. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model. Int J Antimicrob Agents. 2009;34:215–9.

    Article  PubMed  CAS  Google Scholar 

  14. Jantos C, Altmannsberger M, Weidner W, Schiefer HG. Acute and chronic bacterial prostatitis due to E. coli. Description of an animal model. Urol Res. 1990;18:207–11.

    Article  PubMed  CAS  Google Scholar 

  15. Moon TD. Questionnaire survey of urologist and primary care physicians’ diagnostic and treatment practices for prostatitis. Urology. 1997;50:543–7.

    Article  PubMed  CAS  Google Scholar 

  16. Terai A, Yamamoto S, Mitsumori K, Okada Y, Kurazono H, Takeda Y, et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int J Urol. 1997;4:289–94.

    Article  PubMed  CAS  Google Scholar 

  17. Neal DE Jr, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology. 1994;43:460–5.

    Article  PubMed  Google Scholar 

  18. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35:1–12.

    Article  PubMed  Google Scholar 

  19. Wagenlehner FM, Weidner W, Naber KG. An update on uncomplicated urinary tract infections in women. Curr Opin Urol. 2009;19:368–74.

    Article  PubMed  Google Scholar 

  20. Xie X, Eberding A, Madera C, Fazli L, Jia W, Goldenberg L, et al. Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. J Urol. 2006;175:1926–31.

    Article  PubMed  CAS  Google Scholar 

  21. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res. 2004;27:429–35.

    Article  PubMed  CAS  Google Scholar 

  22. Song Z, Johansen HK, Faber V, Moser C, Kharazmi A, Rygaard J, et al. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother. 1997;41(5):961–4.

    PubMed  CAS  Google Scholar 

  23. Yang G, Bao T, Fu N, Geng P. Preliminary study of the modulating effects of ginseng on immunity in vivo and in vitro. Acta Bethune Med Univ. 1983;9:1–4 (in Chinese).

    CAS  Google Scholar 

  24. Yang G, Bao T, Yu Y. Immune modulating effects of ginseng in vivo and in vitro. Commun Med Res. 1987;16:220–1 (in Chinese).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong-Hyun Cho.

About this article

Cite this article

Kim, S.H., Ha, US., Sohn, D.W. et al. Preventive effect of ginsenoid on chronic bacterial prostatitis. J Infect Chemother 18, 709–714 (2012). https://doi.org/10.1007/s10156-012-0406-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-012-0406-7

Keywords

Navigation